Patents Examined by Teresa E Knight
-
Patent number: 8894975Abstract: Methods are provided for, inter alia, determining the presence of leukemia cells in a subject, determining the change or potential change in the number of leukemia cells in the subject with time, determining whether a tissue in a subject contains a plurality of leukemia cells or a plurality progenitor leukemia cells, and determining whether a leukemia therapy administered to a subject is capable of decreasing the number of leukemia cells in a tissue of the subject.Type: GrantFiled: April 19, 2010Date of Patent: November 25, 2014Assignee: The Regents of the University of Colorado, a body CorporateInventors: Lia Gore, Deborah Deryckere, Margaret E. Macy, Natalie Serkova
-
Patent number: 8834936Abstract: A skin care composition comprising an isolated Asteroidea body fluid or extract thereof is described. Uses and methods of use of the composition for the prevention and/or treatment of a skin disorder or condition, such as skin-aging signs, are also described.Type: GrantFiled: June 23, 2009Date of Patent: September 16, 2014Assignee: Innovactiv Inc.Inventors: Martin Beaulieu, Estelle Loing, Catherine Fillion, Patrice Dionne, Alain Lavoie, Alain Thibodeau
-
Patent number: 8834865Abstract: The invention provides methods, compositions, systems, and kits that include an enzyme/substrate co-delivery system. The liquid delivery system includes at least one enzyme encapsulated in a water-soluble polymeric matrix and a substrate for the enzyme in a carrier liquid in which the polymeric matrix is insoluble. When water is added, the polymeric matrix is solubilized and enzyme is released from the matrix, permitting catalytic action upon the substrate.Type: GrantFiled: November 3, 2009Date of Patent: September 16, 2014Assignee: Danisco US Inc.Inventors: Nathaniel T. Becker, Michael Stoner, Mee-Young Yoon
-
Patent number: 8828433Abstract: Bioscaffoldings formed of hydrogels that are crosslinked in situ in an infarcted region of the heart (myocardium) by a Michael's addition reaction or by a disulfide bond formed by an oxidative process are described. Each of the bioscaffoldings described includes hyaluronan as one of the hydrogel components and the other component is selected from collagen, collagen-laminin, poly-1-lysine, and fibrin. The bioscaffolding may further include an alginate component. The bioscaffoldings may have biofunctional groups such as angiogenic factors and stem cell homing factors bound to the collagen, collagen-laminin, poly-1-lysine, or fibrinogen hydrogel component. In particular, the biofunctional groups may be PR11, PR39, VEGF, bFGF, a polyarginine/DNA plasmid complex, or a DNA/polyethyleneimine (PEI) complex. Additionally, the hydrogel components may be injected into the infarct region along with stem cells and microspheres containing stem cell homing factors.Type: GrantFiled: April 19, 2005Date of Patent: September 9, 2014Assignee: Advanced Cardiovascular Systems, Inc.Inventors: Charles Claude, Connie Kwok, Gene Michal, Jihong Qu, Sophia Liao
-
Patent number: 8815535Abstract: The present invention is directed to a disk diffusion assay for determining susceptibility of bacteria to a glycopeptide antibiotic. The assay includes improvements over conventional assays due to the inclusion of polysorbate 80 and Span 80 in the antibacterial solution used to impregnate paper disks used in the assay.Type: GrantFiled: July 26, 2012Date of Patent: August 26, 2014Assignee: The Medicines CompanyInventor: Adam Belley
-
Patent number: 8815232Abstract: The present invention is based, in part, on our discovery of compositions and methods that can be used to systemically deplete arginine and thereby treat arginine-dependent cancers. Our studies indicate that administering a composition that depletes arginine directly to the patient's small intestine will provide effective treatment for arginine-dependent cancers. Moreover, the methods can be carried out in such a way that various sources of arginine are restricted and side effects are minimized. For example, to deplete arginine, one can not only administer an arginine-depleting enzyme directly to the intestinal lumen but can also inhibit endogenous production of arginine, reduce arginine production by intestinal bacteria and limit arginine intake. To minimize side effects, one can inhibit protein breakdown, which may occur as a compensatory mechanism, provide systemic NO from a nitric oxide donor, provide a pressor peptide, and/or provide prostacycline or an analog thereof.Type: GrantFiled: August 25, 2009Date of Patent: August 26, 2014Assignee: Kyon Biotech AGInventors: Slobodan Tepic, Goran Cvetkovic
-
Patent number: 8815298Abstract: A therapeutic composition is described comprising honey or a honey derivative, a surfactant, and at least one topical carrier or vehicle selected from the group consisting of a fatty ester, a wax and a wax-like compound; wherein the composition has been subjected to a sterilization effective dosage of radiation, and wherein the topical carrier or vehicle, when subjected to that dosage, does not substantially modify the properties of the composition present before the sterilization.Type: GrantFiled: April 15, 2005Date of Patent: August 26, 2014Assignee: Medihoney Pty LtdInventor: Anthony Peter Moloney
-
Patent number: 8785142Abstract: The invention relates to an arrangement, comprising a solid carrier and a matrix arranged on the solid carrier, said matrix comprising at least one enzymatically convertible or modifiable molecule and comprising at least one enzyme that can be released by the conversion or modification of the molecule, said enzyme being capable of converting at least one color-changing substrate located in the matrix and/or on the solid carrier.Type: GrantFiled: February 9, 2011Date of Patent: July 22, 2014Inventors: Georg Gübitz, Eva Sigl, Andrea Hasmann, Marc Schröder, Konstantin Schneider, Alexandra Rollett, Franz Kaufmann, Andreas Hafner
-
Patent number: 8785177Abstract: Methods for creating a transient nanoscale opening in a cell membrane and methods for transporting a desired species through the nanoscale opening are provided. A nano-sized needle-like tip can be used to mechanically slice the cell membrane to create a transient, localized nanoscale slit. The nanoscale slit may be used for transferring exogenous molecules into a living cell.Type: GrantFiled: November 5, 2012Date of Patent: July 22, 2014Assignee: The Board of Trustees of the University of Illinois, a body Corporate and Politic of the State of IllinoisInventors: Min-Feng Yu, Kyungsuk Yum, Ning Wang
-
Patent number: 8778681Abstract: It is an object of the present invention to provide a method for efficient differentiation into blood cells. Specifically, in the present invention, when blood cells are produced from pluripotent stem cells such as ES cells or iPS cells in vitro, the cells are cultured under a low oxygen partial pressure to increase the efficiency of differentiating the pluripotent stem cells into hematopoietic progenitor cells, erythroid progenitor cells, and the like, so as to increase the number of finally obtained, desired blood cells.Type: GrantFiled: March 8, 2013Date of Patent: July 15, 2014Assignees: University of Tokyo, Terumo Kabushiki KaishaInventors: Shinya Sano, Koji Eto, Naoya Takayama, Hiromitsu Nakauchi
-
Patent number: 8765416Abstract: The present invention aims to provide a particulate composition containing anhydrous crystalline 2-O-?-D-glucosyl-L-ascorbic acid having a significantly, hardly solidifiable property compared to conventional ones in a grade for use in quasi-drugs; a process for producing the same; and uses thereof. The present invention solves the above object by providing a particulate composition containing anhydrous crystalline 2-O-?-D-glucosyl-L-ascorbic in an amount of over 98.0% by weight but less than 99.9% by weight, on a dry solid basis; or a degree of crystallinity of 90% or higher for anhydrous crystalline 2-O-?-D-glucosyl-L-ascorbic acid; and by providing a process for producing the same and uses thereof.Type: GrantFiled: September 3, 2010Date of Patent: July 1, 2014Assignee: Hayashibara Co., Ltd.Inventors: Takashi Shibuya, Seisuke Izawa, Tomoyuki Nishimoto, Shigeharu Fukuda, Toshio Miyake
-
Patent number: 8765429Abstract: Methods and apparatus for treating biomass that may include introducing a biomass to a chamber; exposing the biomass in the chamber to a shock event to produce a shocked biomass; and transferring the shocked biomass from the chamber. In some aspects, the method may include pretreating the biomass with a chemical before introducing the biomass to the chamber and/or after transferring shocked biomass from the chamber.Type: GrantFiled: March 28, 2012Date of Patent: July 1, 2014Assignee: The Texas A & M University SystemInventors: Mark T. Holtzapple, Maxine Jones Madison, Rocio Sierra Ramirez, Mark A Deimund, Matthew Falls, John J. Dunkleman
-
Patent number: 8741594Abstract: The present invention relates to mitochondrial protein that can be used as a marker for diagnosing stomach cancer. According to the present invention, the marker for diagnosing stomach cancer comprises mitochondrial enoyl coenzyme A hydratase 1.Type: GrantFiled: January 17, 2008Date of Patent: June 3, 2014Assignee: Inje University Industry-Academic Cooperation FoundationInventors: Won Sun Park, Jae-Hong Ko, Na Ri Kim, Jin Han, Hyoung Kyu Kim, Mohamad Warda
-
Patent number: 8735544Abstract: An improved process for obtaining value added by-products from an ethanol production whole stillage is disclosed wherein the whole stillage is mixed with additives to form a nutrition enriched product stream that is subsequently dried to produce a nutrition enriched product having a water content of less than 12% by weight. In a preferred embodiment the whole stillage is obtained from a ethanol production process that has utilized a corn flour as the starting feedstock. The corn flour is then hydrolyzed along with added vitamins and/or nutrients and/or enzymes. The hydrolyzed product is then preferably mixed with a soy hull flour, also preferably having a median particle size of less than about 100 microns, and subjected to conventional fermentation conditions to produce an ethanol containing product. The ethanol-containing product is then distilled to produce an ethanol enriched steam and the separate whole stillage to be used as the feedstock.Type: GrantFiled: September 28, 2005Date of Patent: May 27, 2014Assignee: Little Sioux Corn Processors, LLCInventors: John E. Prevost, Neal A. Hammond
-
Patent number: 8728805Abstract: Provided herein are osteogenic placental adherent cells (OPACs), methods of using OPACs and OPAC populations, and methods of culturing, proliferating, expanding, or differentiating the OPACs. Further provided herein are methods of using the OPACs to formulate implantable or injectable compositions suitable for administration to a subject. Still further provided herein are methods for treating bone defects with OPACs and compositions comprising OPACs. Also provided herein are methods of using OPACs in the treatment and management of multiple myeloma, e.g., reducing the progression of, halting the progression of, or improving, one or more symptoms of multiple myeloma in an individual having multiple myeloma, comprising administering a plurality of OPACs to the individual.Type: GrantFiled: August 24, 2009Date of Patent: May 20, 2014Assignee: Anthrogenesis CorporationInventors: Sascha D. Abramson, Marian Guelakis, Mohammad A. Heidaran, Kristen Labazzo, Shmuel Yaccoby
-
Patent number: 8722911Abstract: A method of processing stillage by hydrothermally fractionating stillage to create unique product fractions, by heating the stillage to a temperature of 250 degrees F. to 350 degrees F., and recovering a stickwater fraction from the stillage. Stickwater, oil, biomass, bio-products, extracts, metabolites, and treated water obtained from the method above. A method of performing ethanol fermentation by hydrothermally fractionating stillage to create unique product fractions by heating the stillage to a temperature of 250 degrees F. to 350 degrees F., separating the stillage into a ProFat fraction and a stickwater fraction, and recovering oil from the ProFat fraction.Type: GrantFiled: April 25, 2013Date of Patent: May 13, 2014Assignee: Valicor, Inc.Inventors: James Robert Bleyer, Thomas J Czartoski, Puneet Chandra
-
Patent number: 8703101Abstract: The present disclosure provides devices and rapid methods to acquire a wound sample to detect and measure NOx, and optionally, one or more other analytes that are indicative of the status of a wound.Type: GrantFiled: August 3, 2010Date of Patent: April 22, 2014Assignee: 3M Innovative Properties CompanyInventors: Stephanie F. Bernatchez, Vinod P. Menon, Joseph J. Stoffel, Joseph A. Tucker
-
Patent number: 8703453Abstract: A range of concentrations exists in which fermentation inhibitors derived from pretreatment of lignocellulosic feed stocks inhibit growth of lactic acid bacteria without affecting fermentive yeast. By optimizing levels of fermentation inhibitors to fall within this range, yeast fermentations of lignocellulosic biomass can be conducted under non-sterile conditions with ethanol yields comparable to those achieved under sterile conditions. Optimised inhibitor levels can be achieved by controlling the water/biomass ratio of a lignocellulosic biomass during and after pretreatment, for example by washing the fiber fraction of a previously pretreated lignocellulosic biomass with a pre-defined amount of fresh water or recycled process solutions. Crude extracts of liquid fraction or process solutions from pretreatment of lignocellulosic biomass can also provide an effective anti-baterial treatment for first generation starch fermentations.Type: GrantFiled: January 24, 2012Date of Patent: April 22, 2014Assignee: Inbicon A/SInventor: Jan Larsen
-
Patent number: 8697054Abstract: The invention relates to a novel strain of Lactobacillus rhamnosus, having antimicrobial and immunomodulatory properties, and to compositions containing said strain.Type: GrantFiled: March 18, 2009Date of Patent: April 15, 2014Assignee: Campagnie Gervais DanoneInventors: Isabelle Chambaud, Artem Khlebnikov, Anne-Catherine Villain, Gianfranco Grompone, Thierry Saint Denis
-
Patent number: 8697390Abstract: The present invention provides simple, rapid methods and procedures for analyzing cells, hereunder quantitative and qualitative assessment of cells. The present invention relates to the use of N-(9-acridinyl)maleimide (NAM) or to the use of 7-diethylamino-3-((4?-(iodoacetyl)amino)phenyl)-4-methylcoumarin (CPI), particularly detectable upon its reaction with species (e.g., sulphur-containing species) present in higher concentrations in intact (e.g., living) cells than in non-intact (e.g., dead) cells. The present invention also relates to the use of NAM or to the use of 7-diethylamino-3-((4?-(iodoacetyl)amino)phenyl)-4-methylcoumarin (CPI), particularly detectable upon its reaction with species present in intact and/or non-intact cells. Moreover, the present invention relates to the use of measuring techniques and/or instruments coupled with the use of NAM or with the use of 7-diethylamino-3-((4?-(iodoacetyl)amino)phenyl)-4-methylcoumarin (CPI).Type: GrantFiled: July 14, 2009Date of Patent: April 15, 2014Assignee: ChemoMetec A/SInventors: Mette Elena Skindersø, Helle Frobøse Sørensen, Søren Kjaerulff